S2 Ep81: Cancer Prevention, Misinformation, and Modern Wellness
The discussion examines the evidence behind common concerns about everyday products, food trends, and lifestyle habits, while emphasizing a practical, individualized approach to health and cancer prev...
16 Kesä 39min
S2 Ep80: It Takes a Village: Bringing Cell & Gene Therapy to Patients
A panel of clinical pharmacists meets to discuss the complex process of operationalizing cell and gene therapy at an academic medical center.
5 Kesä 46min
S2 Ep79: Alzheimer Updates, Stroke Breakthroughs, and the Case for Early Treatment
In this episode of Mind the Meds, Erica Marini, PharmD, highlights information from the European Stroke Organization Conference include encouraging data on asundexian(Bayer), a factor XIa inhibitor sh...
4 Kesä 52min
S2 Ep76: Innovations in Psychiatric Pharmacotherapy From the AAPP Annual Meeting
In this episode of Pharmacy Focus, moderator Bob Haight, PharmD, BCPP, AAPP Annual Meeting director and past president of American Association of Psychiatric Pharmacists (AAPP), discusses the AAPP 202...
20 Touko 29min
S2 Ep78: Hepatitis B Vaccination in Adults: Overcoming Stigma and Improving Protection
You can connect with Marilyn Bulloch on LinkedIn here.Read more insights about hepatitis B throughout Hepatitis Awareness Month at Pharmacy Times' Hepatitis Resource Center.Episode Timestamps:1:05: In...
12 Touko 27min
S2 Ep77: "I've Been Doing Some Research": Wellness, Mistrust, and the Space Between
When a cancer patient says "I've been doing some research," the conversation that follows can be just as complex as the treatment itself. In this episode, a malignant hematology clinical pharmacy spec...
8 Touko 47min
S2 Ep75: Recapping the AAN 2026 Annual Meeting: Neurologic Disease Treatment Is Rapidly Evolving
This inaugural episode of Mind the Meds introduces neurology pharmacy practice through a discussion between 3 neurology pharmacists working across inpatient and outpatient settings at the University o...
7 Touko 1h 7min
S2 Ep74: Sacituzumab Govitecan and the New Standard of Care- What the NCCN Update Means for First-Line Metastatic TNBC
1 Touko 20min
